Publication: PARP7 Regulates FRA1 Protein-Turnover and Thermostability: Implications for Cancer Progression and Treatment
PARP7 Regulates FRA1 Protein-Turnover and Thermostability: Implications for Cancer Progression and Treatment
Date
Date
Date
Citations
Manetsch, P. (2024). PARP7 Regulates FRA1 Protein-Turnover and Thermostability: Implications for Cancer Progression and Treatment. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-259337
Abstract
Abstract
Abstract
Post-translational modifications (PTMs) profoundly impact protein function and are involved in almost all cell biological processes. Various PTMs, including ADP-ribosylation, have also been linked to different pathologies such as cancer. The discovery of the synthetic lethal interaction between PARP1 inhibitors and BRCA-deficient tumors has led to the development of ADP-ribosylation inhibitors as a novel class of anticancer drugs. This has highlighted the potential of ADP-ribosyltransferases as targets for cancer therapy. Recently, it
Additional indexing
Creators (Authors)
Faculty
Faculty
Faculty
Item Type
Item Type
Item Type
Referees
Language
Language
Language
Place of Publication
Place of Publication
Place of Publication
Publication date
Publication date
Publication date
Date available
Date available
Date available
Number of pages
Number of pages
Number of pages
OA Status
OA Status
OA Status
Citations
Manetsch, P. (2024). PARP7 Regulates FRA1 Protein-Turnover and Thermostability: Implications for Cancer Progression and Treatment. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-259337